Fig. 1From: Unveiling difficult-to-treat rheumatoid arthritis: long-term impact of biologic or targeted synthetic DMARDs from the KOBIO registryComparison of b/tsDMARDs between D2T RA and non-D2T RA groups. A Comparison of drug retention between the D2T RA and non-D2T RA groups. B Comparison of drug discontinuation between the D2T RA and non-D2T RA groups. C Comparison of drug switching between the D2T RA and non-D2T RA groupsBack to article page